IP Library Granted Patent US 12,036,196
Granted Patent B2
US 12,036,196 · App. 17/064,506 · Granted Jul 16, 2024

Compositions and methods for the sustained release of beta-alanine

Inventors: Roger Harris (Newmarket, GB); John Wise (San Marcos, CA)
Assignee: Natural Alternatives International, Inc.
A61K31/197A23L33/175A61K9/0095A61K9/06A61K9/48A61K9/4858A61K9/5015A61K31/445A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,036,196
App. No.
17/064,506
Granted
Jul 16, 2024
Kind
B2
Abstract

Methods and compositions are provided for increasing the anaerobic working capacity of muscle and other tissues. Also provided are compositions formulated for the sustained release of free beta-alanine. Also provided is a dietary supplement formulated, for example, as a solid food product, an edible suspension, liquid or semi-liquid as described herein.

Claims (12)

1. A dietary supplement comprising an amount of free beta-alanine, or a salt thereof, wherein the free beta-alanine or salt thereof is formulated as a physical system or a chemical system for sustained release; wherein following ingestion of the dietary supplement a blood concentration of beta-alanine does not exceed 200 μmol/L within 15 minutes following ingestion; and wherein the free beta-alanine, or salt thereof, in the sustained release physical or chemical system is in an effective amount to increase carnosine biosynthesis in muscle to attenuate metabolic acidosis and muscle fatigue during anaerobic activity, wherein the physical system is selected from the group consisting of reservoir systems, monolithic systems, laminated structures, and osmotic pumps and wherein the chemical system is polymer matrix, wherein the effective amount of free beta-alanine, or salt thereof, in the sustained release physical or chemical system is from about 0.1 grams to about 10.0 grams.

2. The dietary supplement of claim 1 , further comprising an amount of a creatine.

3. The dietary supplement of claim 1 , further comprising an amount of a citrulline.

4. A dietary supplement comprising an amount of free beta-alanine, or a salt thereof, wherein the free beta-alanine or salt thereof is formulated as a physical system or a chemical system for sustained release; wherein following ingestion of the dietary supplement a blood concentration of beta-alanine does not exceed 375 μmol/L within 30 minutes following ingestion; and wherein the free beta-alanine, or salt thereof, in the sustained release physical or chemical system is in an effective amount to increase carnosine biosynthesis in muscle to attenuate metabolic acidosis and muscle fatigue during anaerobic activity, wherein the physical system is selected from the group consisting of reservoir systems, monolithic systems, laminated structures, and osmotic pumps and wherein the chemical system is polymer matrix, wherein the effective amount of free beta-alanine, or salt thereof, in the sustained release physical or chemical system is from about 0.1 grams to about 10.0 grams.

5. The dietary supplement of claim 4 , further comprising an amount of a creatine.

6. The dietary supplement of claim 4 , further comprising an amount of a citrulline.

7. A dietary supplement comprising an amount free beta-alanine, or a salt thereof, wherein the free beta-alanine or salt thereof is formulated as a physical system or a chemical system for sustained release; wherein following ingestion of the dietary supplement a blood concentration of beta-alanine does not exceed 300 μmol/L within 45 minutes following ingestion; and wherein the free beta-alanine, or salt thereof, in the sustained release physical or chemical system is in an effective amount to increase carnosine biosynthesis in muscle to attenuate metabolic acidosis and muscle fatigue during anaerobic activity, wherein the physical system is selected from the group consisting of reservoir systems, monolithic systems, laminated structures, and osmotic pumps and wherein the chemical system is polymer matrix, wherein the effective amount of free beta-alanine, or salt thereof, in the sustained release physical or chemical system is from about 0.1 grams to about 10.0 grams.

8. The dietary supplement of claim 7 , further comprising an amount of a creatine.

9. The dietary supplement of claim 7 , further comprising an amount of a citrulline.

10. A dietary supplement comprising an amount of free beta-alanine, or a salt thereof, wherein the free beta-alanine or salt thereof is formulated as a physical system or a chemical system for sustained release; wherein following ingestion of the dietary supplement a blood concentration of beta-alanine does not exceed 100 μmol/L within 75 minutes following ingestion; and wherein the free beta-alanine, or salt thereof, in the sustained release physical or chemical system is in an effective amount to increase carnosine biosynthesis in muscle to attenuate metabolic acidosis and muscle fatigue during anaerobic activity, wherein the physical system is selected from the group consisting of reservoir systems, monolithic systems, laminated structures, and osmotic pumps and wherein the chemical system is polymer matrix, wherein the effective amount of free beta-alanine, or salt thereof, in the sustained release physical or chemical system is from about 0.1 grams to about 10.0 grams.

11. The dietary supplement of claim 10 , further comprising an amount of a creatine.

12. The dietary supplement of claim 10 , further comprising an amount of a citrulline.

Assignments (2)
SECURITY INTEREST Recorded May 18, 2026
From: NATURAL ALTERNATIVES INTERNATIONAL, INC.
To: LEGACY CORPORATE LENDING, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 074684/0430 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2020
From: HARRIS, ROGER; WISE, JOHN
To: NATURAL ALTERNATIVES INTERNATIONAL, INC.
Reel/Frame 053992/0296 →
Continuity (9)
Continuation 15886964 · Feb 2, 2018
Continuation 15240460 · Aug 18, 2016
Continuation 14626739 · Feb 19, 2015
Continuation 13929251 · Jun 27, 2013
Continuation 13755954 · Jan 31, 2013
Continuation 13646184 · Oct 5, 2012
Division 12064005
Provisional Application 60683985 · May 23, 2005
Related Publication 20210260005A1 · Aug 26, 2021